Cancer News and Research

Latest Cancer News and Research

Immunotherapy replaces surgery for early-stage dMMR cancers in landmark study

Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch repair-deficient (dMMR) solid tumors across multiple types. Most patients avoided surgery with durable disease control, reshaping potential cancer treatment pathways.

28 Apr 2025

Humanized antibody dismantles metabolic barrier as a potential cancer immunotherapy

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

28 Apr 2025

Immune evasion found in early stages of HPV-related anogenital lesions

A new research paper was published in Oncotarget, Volume 16, on April 24, 2025, titled "PD-L1 and FOXP3 expression in high-grade squamous intraepithelial lesions of the anogenital region."

28 Apr 2025

Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 mutations – with manageable side effects, according to results from the Phase Ia/Ib Beamion LUNG-1 trial led by researchers from The University of Texas MD Anderson Cancer Center.

28 Apr 2025

New topical gel reduces painful rash from colorectal cancer treatment

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 significantly reduces the severity of an acne-like rash, a common and painful side effect experienced by patients undergoing anti-EGFR therapies for colorectal cancer.

28 Apr 2025

Study links ultraprocessed foods to higher risk of premature deaths, modeling shows

A study analyzing data from nationally representative dietary surveys and mortality data from eight countries (Australia, Brazil, Canada, Chile, Colombia, Mexico, United Kingdom, and United States) shows that premature deaths attributable to consumption of ultraprocessed foods (UPFs) increase significantly according to their share in individuals' total energy intake.

28 Apr 2025

High cannabis use associated with increased colon cancer mortality

Researchers at the University of California San Diego School of Medicine have found that individuals with colon cancer and a documented history of high cannabis use were more than 20 times more likely to die within five years of diagnosis compared to those without such a history.

28 Apr 2025

Adaptive NK cells can effectively target ovarian cancer, study shows

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the immune system, called adaptive NK cells, to remember ovarian tumors and effectively attack them.

28 Apr 2025

Medicare changes set to lower out-of-pocket costs for cancer medications

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000-until recently.

28 Apr 2025

How immune resilience and salutogenesis promote disease resistance and longevity

Researchers examine how salutogenesis, the active production of health through immune resilience, resists disease.

28 Apr 2025

Ultra-processed foods make up nearly half of US grocery purchases, raising public health concerns

A 2025 study of nearly 60,000 US households found that almost half of grocery purchases were ultra-processed foods (UPFs), with major disparities based on income, education, and race. Non-Hispanic white households led in UPF purchases, especially in beverages, reversing earlier trends.

28 Apr 2025

Pre and post-surgical immunotherapy improves survival in head and neck cancer patients

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without the cancer coming back and higher rates of substantial tumor shrinkage prior to surgery, according to the first interim analysis of a randomized, open-label phase 3 clinical trial led by investigators from Dana-Farber Brigham Cancer Center and Washington University School of Medicine in St. Louis.

27 Apr 2025

Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

27 Apr 2025

MD Anderson researchers present promising clinical trial results at AACR 2025

Researchers from The University of Texas MD Anderson Cancer Center will present promising results from clinical trials in three minisymposia abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2025.

26 Apr 2025

Understanding the motivations behind cancer patients' adoption of traditional Chinese medicine

Traditional Chinese medicine (TCM) is widely used in cancer care in China as an integral part of treatment.

26 Apr 2025

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

BioSkryb Genomics and Tecan Group, today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan.

26 Apr 2025

New method improves RMST analysis for clinical and epidemiological studies

The restricted mean survival time (RMST) analysis technique was introduced in health care research about 25 years ago and since then has become widely used in economics, engineering, business and other professions.

26 Apr 2025

Distinct subtypes of senescent skin cells identified

Senescent skin cells, often referred to as zombie cells because they have outlived their usefulness without ever quite dying, have existed in the human body as a seeming paradox, causing inflammation and promoting diseases while also helping the immune system to heal wounds.

26 Apr 2025

New Medicare changes ease cost burden for cancer drugs

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000-until recently.

25 Apr 2025

Exploring ondansetron as potential therapy for opioid-exposed infants

As the opioid crisis continues, the number of babies born with neonatal opioid withdrawal syndrome (NOWS) – a condition that affects infants whose mothers used opioids during pregnancy – has risen 5-fold over the past 20 years.

25 Apr 2025

Previous
1
...
49
50
51
52
53
54
55
...
4539
Next

Cancer News and Research

Latest Cancer News and Research

Immunotherapy replaces surgery for early-stage dMMR cancers in landmark study

Humanized antibody dismantles metabolic barrier as a potential cancer immunotherapy

Immune evasion found in early stages of HPV-related anogenital lesions

Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

New topical gel reduces painful rash from colorectal cancer treatment

Study links ultraprocessed foods to higher risk of premature deaths, modeling shows

High cannabis use associated with increased colon cancer mortality

Adaptive NK cells can effectively target ovarian cancer, study shows

Medicare changes set to lower out-of-pocket costs for cancer medications

How immune resilience and salutogenesis promote disease resistance and longevity

Ultra-processed foods make up nearly half of US grocery purchases, raising public health concerns

Pre and post-surgical immunotherapy improves survival in head and neck cancer patients

Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

MD Anderson researchers present promising clinical trial results at AACR 2025

Understanding the motivations behind cancer patients' adoption of traditional Chinese medicine

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

New method improves RMST analysis for clinical and epidemiological studies

Distinct subtypes of senescent skin cells identified

New Medicare changes ease cost burden for cancer drugs

Exploring ondansetron as potential therapy for opioid-exposed infants

Cancer Research - Second Edition eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in